Lindsey Roeker

21PUBLICATIONS
178CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteinsHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jul 22, 2026
Molecular and Structural Basis of Pan-Resistance to BTK Degraders and Inhibitors.

|Jun 30, 2026
Zanubrutinib, Obinutuzumab, and Venetoclax in CLL: Long-Term Follow Up, MRD Kinetics, Retreatment, T-Cell Profiling, PKs.

|Feb 26, 2026
Fitness beyond age: Multidisciplinary expert opinion on redefining fitness for targeted therapies in chronic lymphocytic leukemia.

Raúl Córdoba, Stephan Stilgenbauer, Paolo Ghia

|Oct 07, 2025
Genomic determinants of response and resistance to pirtobrutinib in relapsed/refractory chronic lymphocytic leukemia.

Jennifer R Brown, Bastien Nguyen, Sai Prasad Desikan

|Oct 14, 2024
HMA/VEN treatment modifications and associated outcomes in IDH-mutant AML.

Kuo-Kai Chin, Andriy Derkach, Christopher Famulare

|Aug 09, 2024
Real-world incidence and prevention of tumor lysis syndrome in chronic lymphocytic leukemia treated with venetoclax.

Yannis K Valtis, David Nemirovsky, Andriy Derkach

Pageof 4

Frequent Collaborators

5 joint publications

Meghan C Thompson

5 joint publications

Andrew Zelenetz

3 joint publications

Justin Taylor

3 joint publications

Jennifer A Woyach